Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
Revue Des Maladies Respiratoires
|
July 1, 2019
[Emergency room management of patients with lung cancer and organ failure]
C Collart, D Moro-Sibilot, M Maignan, et al.
Revue Des Maladies Respiratoires
|
October 16, 2019
[Concomitant use of nivolumab and immunosuppressants in a renal transplant patient]
H Pluchart, L Ferrer, D Giovannini, et al.
Revue Des Maladies Respiratoires
|
September 24, 2018
[IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer]
X Mignard, M Antoine, D Moro-Sibilot, et al.
British Journal of Cancer
|
March 18, 2004
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours
S Lantuejoul, J C Soria, D Moro-Sibilot, et al.
Revue Des Maladies Respiratoires
|
September 18, 2012
[Cavitating nodules in a 40-year-old non-smoking woman: a very particular tumour]
M-V Albahary, G Ferretti, S Lantuejoul, et al.
Revue Des Maladies Respiratoires
|
January 26, 2015
[Assessment of a tool for decision making in case of worsening condition of cancer patients]
A-C Toffart, L Sakhri, N Girard, et al.
Respiratory Medicine and Research
|
January 14, 2020
Impact of systematic advanced care planning in lung cancer patients: A prospective study
N Denis, J-F Timsit, M Giaj Levra, et al.
British Journal of Cancer
|
May 20, 2004
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients
J-L Pujol, O Molinier, W Ebert, et al.
The European Respiratory Journal
|
August 11, 2011
Primary lung adenocarcinoma: characteristics by smoking habit and sex
H Nagy-Mignotte, P Guillem, A Vesin, et al.
Cancer Treatment and Research Communications
|
April 27, 2021
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis
S Ponce Aix, S Novello, E B Garon, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
Revue Des Maladies Respiratoires
|
July 1, 2019
[Emergency room management of patients with lung cancer and organ failure]
C Collart, D Moro-Sibilot, M Maignan, et al.
Revue Des Maladies Respiratoires
|
October 16, 2019
[Concomitant use of nivolumab and immunosuppressants in a renal transplant patient]
H Pluchart, L Ferrer, D Giovannini, et al.
Revue Des Maladies Respiratoires
|
September 24, 2018
[IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer]
X Mignard, M Antoine, D Moro-Sibilot, et al.
British Journal of Cancer
|
March 18, 2004
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours
S Lantuejoul, J C Soria, D Moro-Sibilot, et al.
Revue Des Maladies Respiratoires
|
September 18, 2012
[Cavitating nodules in a 40-year-old non-smoking woman: a very particular tumour]
M-V Albahary, G Ferretti, S Lantuejoul, et al.
Revue Des Maladies Respiratoires
|
January 26, 2015
[Assessment of a tool for decision making in case of worsening condition of cancer patients]
A-C Toffart, L Sakhri, N Girard, et al.
Respiratory Medicine and Research
|
January 14, 2020
Impact of systematic advanced care planning in lung cancer patients: A prospective study
N Denis, J-F Timsit, M Giaj Levra, et al.
British Journal of Cancer
|
May 20, 2004
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients
J-L Pujol, O Molinier, W Ebert, et al.
The European Respiratory Journal
|
August 11, 2011
Primary lung adenocarcinoma: characteristics by smoking habit and sex
H Nagy-Mignotte, P Guillem, A Vesin, et al.
Cancer Treatment and Research Communications
|
April 27, 2021
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis
S Ponce Aix, S Novello, E B Garon, et al.
Page
of 8